Therapy Companies, November 2014

24/7 Customer Support

Talk to Sam

+1 718 473 0872

You might be interested in: Vaccination, Palliative Care, Chemotherapy, more »

54 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

Eli Lilly and Co.

United States

Bristol-Myers Squibb Co.

United States

AstraZeneca PLC

United Kingdom

Abbott Laboratories

United States

Biogen Idec

United States

Lilly and Co.

United States

Bayer AG

Germany

Amgen Inc.

United States

Merck KGaA

Germany

Celgene Corp.

United States

Allergan Inc.

United States

Baxter Healthcare Corp.

United States

Genzyme Corp.

United States

Biogen Idec Inc.

United States

Forest Laboratories Inc.

United States

Covidien PLC

Ireland

Hospira Inc.

United States

Nektar Therapeutics

United States

About 300 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Industry - Company Report, November 2014

  • Boston Therapeutics Reports third Quarter Results and Provides C...
  • November 2014
    6 pages
  • Therapeutics  

  • United States  

    North America  

View report >

Therapy Markets In The Us

September 2014

About 2 200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 7 995)

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • August 2014
  • by Global Data

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018 Summary The main drivers of growth in graft versus host disease over the 2013-2018 forecast period include the ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.